Clinical Trial Update: Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial update for PH3 in preventing osteoporosis in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• PH3

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED